Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8563027 Drug delivery through hydrogel plugs

Patent 8563027 was granted and assigned to Incept on October, 2013 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Incept

Current Assignee

Incept

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8563027

Date of Patent

October 22, 2013

Patent Application Number

13777103

Date Filed

February 26, 2013

Patent Citations Received

‌

US Patent 12109302 Sustained release biodegradable intracanalicular inserts comprising a hydrogel and cyclosporine

‌

US Patent 12011390 Lacrimal drug delivery device

‌

US Patent 12023276 Intracanalicular depot inserter device

‌

US Patent 12102516 Products with materials that shrink in one dimension and expand in another dimension

‌

US Patent 11779536 Sustained release biodegradable intracanalicular inserts comprising a hydrogel and cyclosporine

‌

US Patent 11857461 Lacrimal system for drug delivery

‌

US Patent 11890393 Methods and devices for in situ formed nerve cap

‌

US Patent 11918595 Methods, agents, and devices for local neuromodulation of autonomic nerves

...

Patent Primary Examiner

‌

Sean Basquill

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8563027 Drug delivery through hydrogel plugs

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API